Vomiting plus facial swelling after iron sucrose should be treated as a possible hypersensitivity reaction until proven otherwise. Facial or periorbital swelling is a sign of angioedema. That makes this a potentially severe reaction, not just a mild infusion reaction.
Act now
- Stop the infusion and keep the IV line open with 0.9% saline. Don't flush more iron.
- Assess airway, breathing and circulation immediately. Check BP, pulse, SpO2, and look for stridor, wheeze, hoarseness, tongue or lip swelling, urticaria, and hypotension.
- If there is airway involvement, wheeze, hypotension, or swelling that is progressing, treat as anaphylaxis:
- Give IM epinephrine 0.3 to 0.5 mg (1 mg/mL), repeated every 5 to 15 minutes if needed.
- Give oxygen and IV fluids, and call for help or a rapid response.
- Transfer to an acute care setting.
- This is the textbook regimen (Goldman-Cecil Medicine, Intravenous Iron Therapy section).
- For a milder reaction (hemodynamically stable, no airway signs), IV fluids (e.g., 500 mL saline) and IV corticosteroids (e.g., hydrocortisone) are used. Observe closely, because it can progress.
- Avoid diphenhydramine premedication or treatment as a reflex. Goldman-Cecil states it can worsen symptoms in iron infusion reactions. It is not a substitute for epinephrine in anaphylaxis.
Which kind of reaction is it?
| Feature | Fishbane reaction (CARPA) | True anaphylaxis (IgE-mediated or severe) |
|---|
| Mechanism | Complement activation by labile free iron, a pseudoallergy | Immediate hypersensitivity |
| Typical signs | Flushing, chest tightness, back pain, myalgia, arthralgia, usually no hypotension or hypoxia | Hypotension, wheeze, stridor, periorbital or facial edema, cyanosis, confusion, collapse |
| Course | Self-limited, resolves in minutes after stopping | Progressive, needs epinephrine |
Goldman-Cecil Medicine says these reactions are mostly complement activation-related pseudoallergy. Mild reactions occur in about 1 in 200 infusions and major reactions in about 1 in 200,000. Reactions needing hospitalization are very rare but can occur with any iron product.
Facial swelling with vomiting goes beyond a typical Fishbane reaction.
Expert consensus guidance lists periorbital edema among the features of a severe reaction.
Background on iron sucrose
- Brenner and Rector's The Kidney says iron sucrose has an excellent safety record. It estimates life-threatening reactions at about 0.6 per million doses, versus 11.3 per million for high molecular weight iron dextran.
- The same text notes allergic reactions have been reported for all brands, and most mild events don't recur on rechallenge.
- The National Kidney Foundation Primer says iron sucrose has never been linked to a fatal anaphylactic reaction and needs no test dose.
- A test dose is not helpful for these non-allergic reactions (Goldman-Cecil Medicine).
After the event
- Observe until symptoms have fully resolved. Reactions can recur after improving, so monitor for several hours if the reaction was significant.
- Document the product, dose, rate and timing, along with the symptoms and treatment.
- Consider a serum tryptase drawn 1 to 3 hours after onset if anaphylaxis is suspected. This is my addition from general practice and not from the sources I retrieved.
- Report the event through your pharmacovigilance system.
- Future iron therapy: mild, resolved Fishbane-type reactions often allow a slower rechallenge with the same or a different IV iron. After a reaction with facial or airway involvement, get an allergy or hematology opinion before any further IV iron. Options include oral iron, or a different IV formulation given slowly under monitoring.
- Other causes of vomiting plus swelling, such as a food or drug allergen or an unrelated angioedema (including from ACE inhibitors), are worth considering if the timing doesn't fit.
Evidence check
A recent
meta-analysis comparing ferric carboxymaltose and iron sucrose (PMID 40091548, 2025) turned up. It covers efficacy and tolerability and does not contradict the library guidance above.
I don't know the patient's vital signs, timing, or the dose and rate given. The decision to give epinephrine rests on whether the airway, breathing or circulation are affected. This is general information and doesn't replace bedside clinical judgment or your local protocol.
If you tell me the vitals, the onset time and the infusion details, I can help grade the severity.